Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1Terminated 1Recruiting 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Thyroid Nodule 2Breast Neoplasms 2Thyroid Neoplasms 1Recurrence 1Pancreatic Neuroendocrine Tumors, WHO Grade I-II 1Neuroma 1Neuralgia 1Lymphoma, Follicular 1Liver Metastasis Colon Cancer 1Lipoma 1Klatskin Tumor 1Kidney Neoplasms 1Hypesthesia 1Esophageal Neoplasms 1Cicatrix 1Carcinoma, Hepatocellular 1Bone Cancer Metastatic 1Bile Duct Neoplasms 1Agnosia 1Adrenocortical Adenoma 1Adenoma, Islet Cell 1

Interventions

Magnetic Resonance Spectroscopy 4Surgical Procedures, Operative 3Iodine-131 3Iodine-124 3Biopsy 3selpercatinib 2lenvatinib 2Watchful Waiting 2Thyrotropin Alfa 2Therapeutics 2Nivolumab 2Fluorodeoxyglucose F18 2Cyclophosphamide 2Cetuximab 2Biopsy, Fine-Needle 2trastuzumab deruxtecan 1trametinib 1sintilimab 1sacituzumab govitecan 1repotrectinib 1pralsetinib 1pembrolizumab 1gallium Ga 68 dotatate 1fludarabine phosphate 1defactinib 1dabrafenib 1cemiplimab 1brodalumab 1binimetinib 1anlotinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Thyroid Neoplasms × Radiofrequency Ablation × Clear all
NCT06929650 2025-04-16

The Safety and Feasibility of Radiofrequency Ablation to Treat Low-risk Thyroid Cancer

University Health Network, Toronto

Phase NA Recruiting
40 enrolled
Head & Neck

Thyroid Neoplasms, Thyroid Nodule

Data powered by HemOnc (CC BY 4.0) Colophon âš¡